Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement

SYDNEY, September 27, 2010 – Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute
of Medical Research (Sydney, Australia) today announced that they have
entered into a license agreement in relation to novel biomarkers discovered
by scientists at the Garvan Institute. Under the terms of the agreement,
Clinical Genomics obtains worldwide exclusive rights to the Garvan's
proprietary cancer [...]

Announcing the Inaugural ACS Careers’ Virtual Career Fair in Conjunction with Informex and C&EN

100% Virtual Show in November Will Facilitate Networking Opportunities, Deliver Educational Content and Connect Employers with Potential Employees

PRINCETON, New Jersey, September 27, 2010 – The American Chemical Society, Informex, and Chemical & Engineering News
(C&EN) announced today that they are to partner in hosting the 'ACS Careers
Virtual Career Fair in conjunction with Informex and C&EN' [...]

Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases

SAN DIEGO, September 27, 2010 – Amira Pharmaceuticals, Inc. announced today that it has submitted an
Investigational New Drug (IND) application to the US Food and Drug
Administration (FDA) for AM152, a novel LPA1 antagonist. If accepted, the IND
will enable Amira to begin Phase 1 safety studies with the compound in
healthy subjects.

"We [...]